These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10454641)

  • 1. Novel cationic amphiphiles as delivery agents for antisense oligonucleotides.
    DeLong RK; Yoo H; Alahari SK; Fisher M; Short SM; Kang SH; Kole R; Janout V; Regan SL; Juliano RL
    Nucleic Acids Res; 1999 Aug; 27(16):3334-41. PubMed ID: 10454641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.
    Kanamaru T; Takagi T; Takakura Y; Hashida M
    J Drug Target; 1998; 5(4):235-46. PubMed ID: 9713974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells.
    Lappalainen K; Urtti A; Söderling E; Jääskeläinen I; Syrjänen K; Syrjänen S
    Biochim Biophys Acta; 1994 Dec; 1196(2):201-8. PubMed ID: 7841184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
    Bennett CF; Mirejovsky D; Crooke RM; Tsai YJ; Felgner J; Sridhar CN; Wheeler CJ; Felgner PL
    J Drug Target; 1998; 5(3):149-62. PubMed ID: 9606005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents.
    Kang SH; Zirbes EL; Kole R
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):497-505. PubMed ID: 10645775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.
    Yoo H; Juliano RL
    Nucleic Acids Res; 2000 Nov; 28(21):4225-31. PubMed ID: 11058121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression.
    Alahari SK; DeLong R; Fisher MH; Dean NM; Viliet P; Juliano RL
    J Pharmacol Exp Ther; 1998 Jul; 286(1):419-28. PubMed ID: 9655887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).
    Hope MJ; Mui B; Ansell S; Ahkong QF
    Mol Membr Biol; 1998; 15(1):1-14. PubMed ID: 9595549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes.
    Ming X; Sato K; Juliano RL
    J Control Release; 2011 Jul; 153(1):83-92. PubMed ID: 21571016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cationic liposomes on intracellular trafficking and efficacy of antisense oligonucleotides in mouse peritoneal macrophages.
    Takagi T; Hashiguchi M; Hiramatsu T; Yamashita F; Takakura Y; Hashida M
    J Drug Target; 2000; 7(5):363-71. PubMed ID: 10721798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.
    Shi F; Nomden A; Oberle V; Engberts JB; Hoekstra D
    Nucleic Acids Res; 2001 May; 29(10):2079-87. PubMed ID: 11353077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a Quality-By-Design Approach to Optimise Lipid-Polymer Hybrid Nanoparticles Loaded with a Splice-Correction Antisense Oligonucleotide: Maximising Loading and Intracellular Delivery.
    Thanki K; Papai S; Lokras A; Rose F; Falkenberg E; Franzyk H; Foged C
    Pharm Res; 2019 Jan; 36(3):37. PubMed ID: 30623253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of antisense oligonucleotides using cholesterol-modified sense dendrimers and cationic lipids.
    Chaltin P; Margineanu A; Marchand D; Van Aerschot A; Rozenski J; De Schryver F; Herrmann A; Müllen K; Juliano R; Fisher MH; Kang H; De Feyter S; Herdewijn P
    Bioconjug Chem; 2005; 16(4):827-36. PubMed ID: 16029024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAMAM dendrimers as delivery agents for antisense oligonucleotides.
    Yoo H; Sazani P; Juliano RL
    Pharm Res; 1999 Dec; 16(12):1799-804. PubMed ID: 10644065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of antisense oligonucleotides by molecular conjugates.
    Bunnell BA; Askari FK; Wilson JM
    Somat Cell Mol Genet; 1992 Nov; 18(6):559-69. PubMed ID: 1287854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
    Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cationic derivative of amphotericin B as a novel delivery system for antisense oligonucleotides.
    Garcia-Chaumont C; Seksek O; Jolles B; Bolard J
    Antisense Nucleic Acid Drug Dev; 2000 Jun; 10(3):177-84. PubMed ID: 10905554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid conjugated oligonucleotides: a useful strategy for delivery.
    Raouane M; Desmaële D; Urbinati G; Massaad-Massade L; Couvreur P
    Bioconjug Chem; 2012 Jun; 23(6):1091-104. PubMed ID: 22372953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
    Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
    Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomolar cellular antisense activity of peptide nucleic acid (PNA) cholic acid ("umbrella") and cholesterol conjugates delivered by cationic lipids.
    Shiraishi T; Nielsen PE
    Bioconjug Chem; 2012 Feb; 23(2):196-202. PubMed ID: 22243634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.